Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

US10919865B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10919865-B2
Application numberUS-201916291193-A
CountryUS
Kind codeB2
Filing dateMar 4, 2019
Priority dateApr 22, 2011
Publication dateFeb 16, 2021
Grant dateFeb 16, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are Diaminopyrimidine Compounds having the following structures: wherein R 1 , R 2 , R 3 , and R 4 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidine Compound, and methods for treating or preventing liver fibrotic disorders or a condition treatable or preventable by inhibition of a JNK pathway.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for preparing a compound of formula (I): the method comprising contacting a compound of formula (Ia) with R 1 NH 2 in a solvent, in the presence of an organic base, wherein: R 1 is substituted or unsubstituted C 1-8 alkyl, substituted or unsubstituted saturated or partially saturated cycloalkyl, substituted or unsubstituted non-aromatic heterocyclyl, substituted or unsubstituted alkyl-(saturated or partially saturated cycloalkyl), or substituted or unsubstituted alkylheterocyclyl, provided that R 1 is not 2 aminocyclohexyl; R 2 is substituted or unsubstituted C 1-8 alkyl, substituted or unsubstituted saturated C 5-10 cycloalkyl, substituted or unsubstituted alkyl-(saturated or partially saturated cycloalkyl, substituted or unsubstituted non-aromatic heterocyclyl; R x is a C 1-2 alkyl; and m is 1 or 2, wherein when a C 1-8 alky group is substituted, the C 1-8 alkyl group is substituted with halogen, alkyl, hydroxyl, alkoxy, alkoxyalkyl, amino, alkylamino, carboxy, nitro, cyano, thiol, thioether, imine, imide, amidine, guanidine, enamine, aminocarbonyl, acylamino, phosphonato, phosphine, thiocarbonyl, sulfonyl, sulfone, sulfonamide, ketone, aldehyde, ester, urea, urethane, oxime, hydroxyl amine, alkoxyamine, aralkoxyamine, N-oxide, hydrazine, hydrazide, hydrazone, azide, isocyanate, isothiocyanate, cyanate, thiocyanate, B(OH) 2 , or O(alkyl)aminocarbonyl; wherein when a group, other than a C 1-8 alkyl group, is substituted, the group is substituted with halogen, alkyl, hydroxyl, alkoxy, alkoxyalkyl, amino, alkylamino, carboxy, nitro, cyano, thiol, thioether, imine, imide, amidine, guanidine, enamine, aminocarbonyl, acylamino, phosphonato, phosphine, thiocarbonyl, sulfonyl, sulfone, sulfonamide, ketone, aldehyde, ester, urea, urethane, oxime, hydroxyl amine, alkoxyamine, aralkoxyamine, N-oxide, hydrazine, hydrazide, hydrazone, azide, isocyanate, isothiocyanate, cyanate, thiocyanate, oxo, B(OH) 2 , O(alkyl)aminocarbonyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, aryloxy, aralkyloxy, heterocyclyloxy or heterocyclylalkoxy. 2. The method of claim 1 , further comprising preparing a compound of formula (Ia): the method comprising oxidizing a compound of formula (Ib) in a solvent by treatment with an oxidant selected from mCPBA, oxone, hydrogen peroxide, or 3-phenyl-2-(phenylsulfonyl)-1,2-oxaziridine. 3. The method of claim 2 , further comprising preparing a compound of formula (Ib): the method comprising contacting a compound of formula (Ic) with NH 4 Cl, in the presence of a coupling agent and a base, in a solvent. 4. The method of claim 3 , further comprising preparing a compound of formula (Ic) the method comprising contacting a compound of formula (Id) with an aqueous base, in a cosolvent. 5. The method of claim 4 , further comprising preparing a compound of formula (Id) the method comprising contacting a compound of formula (Ie) with R 2 NH 2 in an organic solvent, in the presence of a base. 6. A method for preparing a compound of formula (I): the method comprising (1) contacting a compound of formula (If) with peroxide, in the presence of a base, in a solvent to give a compound of formula (Ib) (2) oxidizing the compound of formula (Ib) in a solvent by treatment with an oxidant selected from mCPBA, oxone, hydrogen peroxide, or 3-phenyl-2-(phenylsulfonyl)-1,2-oxaziridine to give a compound of formula (Ia): (3) contacting the compound of formula (Ia) with R 1 NH 2 in a solvent, in the presence of an organic base, wherein: R 1 is substituted or unsubstituted C 1-8 alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted non-aromatic heterocyclyl, substituted or unsubstituted alkylcycloalkyl, or substituted or unsubstituted alkylheterocyclyl, provided that R 1 is not 2-aminocyclohexyl; R 2 is substituted or unsubstituted C 1-8 alkyl, substituted or unsubstituted saturated cycloalkyl, substituted or unsubstituted alkylcycloalkyl, substituted or unsubstituted non-aromatic heterocyclyl; R x is a C 1-2 alkyl; and m is 1 or 2. 7. The method of claim 6 , further comprising preparing a compound of formula (If) the method comprising contacting a compound of formula (Ig) with R 2 NH 2 in an organic solvent, in the presence of a base. 8. The method of claim 1 , wherein the compound of Formula (I) is 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide. 9. A method for preparing a compound of formula (I): the method comprising contacting a compound of formula (IIa) with R 2 NH 2 in a solvent, in the presence of an organic base, wherein: R 1 is substituted or unsubstituted C 1-8 alkyl, substituted or unsubstituted saturated or partially saturated cycloalkyl, substituted or unsubstituted non-aromatic heterocyclyl, substituted or unsubstituted alkyl-(saturated or partially saturated cycloalkyl), or substituted or unsubstituted alkylheterocyclyl, provided that R 1 is not 2 aminocyclohexyl; R 2 is substituted or unsubstituted C 1-8 alkyl, substituted or unsubstituted saturated C 5-10 cycloalkyl, substituted or unsubstituted alkyl-(saturated or partially saturated cycloalkyl, substituted or unsubstituted non-aromatic heterocyclyl; R x is a C1-2 alkyl; and m is 1 or 2, wherein when a C 1-8 alky group is substituted, the C 1-8 alkyl group is substituted with halogen, alkyl, hydroxyl, alkoxy, alkoxyalkyl, amino, alkylamino, carboxy, nitro, cyano, thiol, thioether, imine, imide, amidine, guanidine, enamine, aminocarbonyl, acylamino, phosphonato, phosphine, thiocarbonyl, sulfonyl, sulfone, sulfon

Assignees

Inventors

Classifications

  • for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants · CPC title

  • One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine · CPC title

  • One sulfur atom · CPC title

  • C07D239/48Primary

    Two nitrogen atoms · CPC title

  • Antineoplastic agents · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10919865B2 cover?
Provided herein are Diaminopyrimidine Compounds having the following structures: wherein R 1 , R 2 , R 3 , and R 4 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidine Compound, and methods for treating or preventing liver fibrotic d…
Who is the assignee on this patent?
Signal Pharm Llc
What technology area does this patent fall under?
Primary CPC classification C07D239/48. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).